147 related articles for article (PubMed ID: 11747272)
1. Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas.
Ghossein RA; Bhattacharya S
Semin Surg Oncol; 2001 Jun; 20(4):304-11. PubMed ID: 11747272
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection and characterisation of circulating tumour cells and micrometastases in solid tumours.
Ghossein RA; Bhattacharya S
Eur J Cancer; 2000 Aug; 36(13 Spec No):1681-94. PubMed ID: 10959054
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
5. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
6. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
7. Review: polymerase chain reaction detection of micrometastases and circulating tumor cells: application to melanoma, prostate, and thyroid carcinomas.
Ghossein RA; Carusone L; Bhattacharya S
Diagn Mol Pathol; 1999 Dec; 8(4):165-75. PubMed ID: 10617272
[TBL] [Abstract][Full Text] [Related]
8. Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors.
Kruck S; Gakis G; Stenzl A
Anticancer Res; 2011 Jun; 31(6):2053-7. PubMed ID: 21737622
[TBL] [Abstract][Full Text] [Related]
9. Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction.
Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI
Diagn Mol Pathol; 1999 Jun; 8(2):59-65. PubMed ID: 10475379
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.
Ghossein RA; Rosai J
Cancer; 1996 Jul; 78(1):10-6. PubMed ID: 8646704
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance for detection of circulating cancer cells in renal cell carcinoma].
Uemura H; Hirao Y
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1712-8. PubMed ID: 12402419
[TBL] [Abstract][Full Text] [Related]
12. Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells.
Li G; Passebosc-Faure K; Gentil-Perret A; Lambert C; Genin C; Tostain J
Anticancer Res; 2005; 25(1A):377-81. PubMed ID: 15816561
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
[TBL] [Abstract][Full Text] [Related]
14. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of micrometastases and circulating tumor cells in solid tumors.
Ghossein RA; Bhattacharya S; Rosai J
Clin Cancer Res; 1999 Aug; 5(8):1950-60. PubMed ID: 10473071
[TBL] [Abstract][Full Text] [Related]
16. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.
McKiernan JM; Buttyan R; Bander NH; de la Taille A; Stifelman MD; Emanuel ER; Bagiella E; Rubin MA; Katz AE; Olsson CA; Sawczuk IS
Cancer; 1999 Aug; 86(3):492-7. PubMed ID: 10430258
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
Müller M; Goessl C; Krause H; Miller K
Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
[TBL] [Abstract][Full Text] [Related]
19. [Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 in patients with renal cell carcinoma].
Hioki T; Sugimura Y
Hinyokika Kiyo; 1999 Aug; 45(8):577-81. PubMed ID: 10500966
[TBL] [Abstract][Full Text] [Related]
20. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
Uemura H
Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
